UPDATE: Q2 Revenues Spike 19 Percent for Bruker | GenomeWeb

This story has been updated to include comments from a conference call discussing the company's earnings.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker reported a 19 percent spike in second-quarter revenues to $300.9 million.

The company's revenues for the three months ended June 30 compared to $252.5 million from the second quarter a year ago. Excluding the effects of acquisitions and foreign currency translation, revenues for the quarter were up 20 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.